The global cold remedies market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing awareness about the benefits of natural remedies for cold and flu, growing demand for over-the-counter (OTC) medicines, and rising incidence of respiratory tract infections.
Antihistamines are expected to be the fastest growing segment in the global cold remedies market during the forecast period. Antihistamines are used to relieve symptoms such as sneezing, runny nose, watery eyes, and itchy throat caused by allergies or hay fever. They also help relieve coughs caused by a common cold or flu virus. Antihistamines work by blocking histamine receptors in cells that produce allergic reactions in order to reduce inflammation and other symptoms associated with allergies or hay fever.
Expectorants are expected to be one of the fastest growing segments in this market during the forecast period due to their ability to loosen mucus from airways which helps clear congestion and make breathing easier while relieving coughs caused by a common cold or flu virus. Expectorants work by thinning mucus so that it can be coughed up more easily without causing pain when coughing up phlegm from lungs which may contain viruses that cause respiratory tract infections like pneumonia or bronchitis among others.
Some Of The Growth Factors Of This Market:
- The growth of the cold remedies market is driven by the increasing prevalence of respiratory tract infections and flu, which are major causes for colds.
- Increasing awareness about the benefits of natural ingredients in medicines.
- Increasing demand for over-the-counter (OTC) medicines.
- Growing preference for natural ingredients.
Industry Growth Insights published a new data on “Cold Remedies Market”. The research report is titled “Cold Remedies Market research by Types (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others), By Applications (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others), By Players/Companies Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, AstraZeneca, Sun Pharmaceutical Industries, Pfizer, Prestige Brands Holdings, Procter & Gamble”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cold Remedies Market Research Report
By Type
Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others
By Application
Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others
By Companies
Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, AstraZeneca, Sun Pharmaceutical Industries, Pfizer, Prestige Brands Holdings, Procter & Gamble
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Cold Remedies Market Report Segments:
The global Cold Remedies market is segmented on the basis of:
Types
Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Reckitt Benckiser Group
- Johnson & Johnson
- GlaxoSmithKline
- Novartis
- Bayer
- AstraZeneca
- Sun Pharmaceutical Industries
- Pfizer
- Prestige Brands Holdings
- Procter & Gamble
Highlights of The Cold Remedies Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antihistamines
- Expectorants
- Bronchodilators
- Decongestants
- Antibiotics
- Others
- By Application:
- Antihistamines
- Expectorants
- Bronchodilators
- Decongestants
- Antibiotics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cold Remedies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cold remedies are medications that are used to treat a cold. They can be taken orally, nasally, or by injection. Cold remedies work by reducing the symptoms of a cold, such as fever, cough, and sneezing.
Some of the major companies in the cold remedies market are Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, AstraZeneca, Sun Pharmaceutical Industries, Pfizer, Prestige Brands Holdings, Procter & Gamble.
The cold remedies market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cold Remedies Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cold Remedies Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cold Remedies Market - Supply Chain
4.5. Global Cold Remedies Market Forecast
4.5.1. Cold Remedies Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cold Remedies Market Size (000 Units) and Y-o-Y Growth
4.5.3. Cold Remedies Market Absolute $ Opportunity
5. Global Cold Remedies Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Cold Remedies Market Size and Volume Forecast by Type
5.3.1. Antihistamines
5.3.2. Expectorants
5.3.3. Bronchodilators
5.3.4. Decongestants
5.3.5. Antibiotics
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Cold Remedies Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Cold Remedies Market Size and Volume Forecast by Application
6.3.1. Antihistamines
6.3.2. Expectorants
6.3.3. Bronchodilators
6.3.4. Decongestants
6.3.5. Antibiotics
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Cold Remedies Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Cold Remedies Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Cold Remedies Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Cold Remedies Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Cold Remedies Demand Share Forecast, 2019-2029
9. North America Cold Remedies Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Cold Remedies Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Cold Remedies Market Size and Volume Forecast by Application
9.4.1. Antihistamines
9.4.2. Expectorants
9.4.3. Bronchodilators
9.4.4. Decongestants
9.4.5. Antibiotics
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Cold Remedies Market Size and Volume Forecast by Type
9.7.1. Antihistamines
9.7.2. Expectorants
9.7.3. Bronchodilators
9.7.4. Decongestants
9.7.5. Antibiotics
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Cold Remedies Demand Share Forecast, 2019-2029
10. Latin America Cold Remedies Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Cold Remedies Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Cold Remedies Market Size and Volume Forecast by Application
10.4.1. Antihistamines
10.4.2. Expectorants
10.4.3. Bronchodilators
10.4.4. Decongestants
10.4.5. Antibiotics
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Cold Remedies Market Size and Volume Forecast by Type
10.7.1. Antihistamines
10.7.2. Expectorants
10.7.3. Bronchodilators
10.7.4. Decongestants
10.7.5. Antibiotics
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Cold Remedies Demand Share Forecast, 2019-2029
11. Europe Cold Remedies Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Cold Remedies Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Cold Remedies Market Size and Volume Forecast by Application
11.4.1. Antihistamines
11.4.2. Expectorants
11.4.3. Bronchodilators
11.4.4. Decongestants
11.4.5. Antibiotics
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Cold Remedies Market Size and Volume Forecast by Type
11.7.1. Antihistamines
11.7.2. Expectorants
11.7.3. Bronchodilators
11.7.4. Decongestants
11.7.5. Antibiotics
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Cold Remedies Demand Share, 2019-2029
12. Asia Pacific Cold Remedies Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Cold Remedies Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Cold Remedies Market Size and Volume Forecast by Application
12.4.1. Antihistamines
12.4.2. Expectorants
12.4.3. Bronchodilators
12.4.4. Decongestants
12.4.5. Antibiotics
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Cold Remedies Market Size and Volume Forecast by Type
12.7.1. Antihistamines
12.7.2. Expectorants
12.7.3. Bronchodilators
12.7.4. Decongestants
12.7.5. Antibiotics
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Cold Remedies Demand Share, 2019-2029
13. Middle East & Africa Cold Remedies Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Cold Remedies Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Cold Remedies Market Size and Volume Forecast by Application
13.4.1. Antihistamines
13.4.2. Expectorants
13.4.3. Bronchodilators
13.4.4. Decongestants
13.4.5. Antibiotics
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Cold Remedies Market Size and Volume Forecast by Type
13.7.1. Antihistamines
13.7.2. Expectorants
13.7.3. Bronchodilators
13.7.4. Decongestants
13.7.5. Antibiotics
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Cold Remedies Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Cold Remedies Market: Market Share Analysis
14.2. Cold Remedies Distributors and Customers
14.3. Cold Remedies Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Reckitt Benckiser Group
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Johnson & Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GlaxoSmithKline
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novartis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bayer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. AstraZeneca
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sun Pharmaceutical Industries
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pfizer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Prestige Brands Holdings
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Procter & Gamble
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
